TrialThe Pediatric infectious disease journal2015

Safety, Pharmacokinetics and Efficacy of Dolutegravir in Treatment-experienced HIV-1 Infected Adolescents: Forty-eight-week Results from IMPAACT P1093.

Rolando M Viani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.